This week on Executive Suite: MindImmune Therapeutics President and CEO Stevin Zorn and Slater Technology Fund senior managing director Richard Horan discuss the URI-based startup’s cutting-edge work on brain diseases and its new alliance with pharmaceutical giant Pfizer.
https://lintvwnac.files.wordpress.com/2018/02/exec-suite-2-22-2018-mindimmune.mp3Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More